Monoclonal gammopathy of undetermined significance: an update for nephrologists.
Adv Chronic Kidney Dis
; 19(5): 291-6, 2012 Sep.
Article
en En
| MEDLINE
| ID: mdl-22920639
ABSTRACT
Screening for a monoclonal protein is a common part of the assessment of patients presenting with a renal injury. While in the settings of acute kidney injury, chronic kidney disease and proteinuria monoclonal proteins can be associated with significant pathologies such as cast nephropathy, amyloidosis, and light chain deposition disease, they can also be an unrelated finding. The purpose of this review is to provide the nephrologist with an update to the diagnostic assessment and risk stratification of monoclonal proteins to avoid unnecessary investigation and monitoring of those patients with low-risk monoclonal gammopathies.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Lesiones Precancerosas
/
Gammopatía Monoclonal de Relevancia Indeterminada
/
Inmunoglobulinas
Tipo de estudio:
Etiology_studies
/
Risk_factors_studies
Límite:
Humans
Idioma:
En
Revista:
Adv Chronic Kidney Dis
Asunto de la revista:
NEFROLOGIA
Año:
2012
Tipo del documento:
Article
País de afiliación:
Reino Unido